JNJ实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (3 May 2024 @ 04:00):

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide...

Stats
今日成交量	8.30M
平均成交量	7.75M
市值	361.27B
EPS	$0 ( 2024-04-16 )
下一个收益日期	( $2.73 ) 2024-07-18
Last Dividend	$1.190 ( 2023-11-20 )
Next Dividend	$0 ( N/A )
P/E	22.28
ATR14	$0.0920 (0.06%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-25	Beckerle Mary C	Buy	1 386	Deferred Share Units
2024-04-25	Hewson Marillyn A	Buy	1 386	Deferred Share Units
2024-04-25	West Nadja	Buy	1 386	Deferred Share Units
2024-04-25	Adamczyk Darius	Buy	1 386	Deferred Share Units
2024-04-25	Woods Eugene A.	Buy	1 386	Deferred Share Units

INSIDER POWER
70.82
Last 100 transactions
Buy: 830 870 \| Sell: 142 333

音量相关性

長: 0.05 (neutral)

短: 0.87 (strong)

Signal:(68.619) Same movement expected

Johnson & Johnson 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Johnson & Johnson 相关性 - 货币/商品

0.69
( moderate )

0.75
( moderate )

0.00
( neutral )

0.75
( moderate )

-0.77
( moderate negative )

-0.32
( neutral )

Johnson & Johnson 财务报表

Annual	2023
营收:	$85.15B
毛利润:	$58.41B (68.60 %)
EPS:	$14.60

FY	2023
营收:	$85.15B
毛利润:	$58.41B (68.60 %)
EPS:	$14.60

FY	2022
营收:	$94.94B
毛利润:	$63.85B (67.26 %)
EPS:	$6.83

FY	2022
营收:	$94.94B
毛利润:	$63.85B (67.26 %)
EPS:	$6.82

Financial Reports:

No articles found.

Johnson & Johnson Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$1.130 (N/A)	$1.130 (N/A)	$1.130 (N/A)	$1.190 (N/A)	$1.190 (N/A)	$1.190 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Johnson & Johnson Dividend Information - Dividend King

Dividend Sustainability Score: 7.59 - good (75.85%) | Divividend Growth Potential Score: 5.52 - Stable (10.44%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.00208	1970-02-16
Last Dividend	$1.190	2023-11-20
Next Dividend	$0	N/A
Payout Date	2023-12-05
Next Payout Date	N/A
# dividends	216	--
Total Paid Out	$62.63	--
Avg. Dividend % Per Year	1.76%	--
Score	5.17	--
Div. Sustainability Score	7.59
Div.Growth Potential Score	5.52
Div. Directional Score	6.55	--

Next Divdend (Est)
(2024-07-01)

$1.200 Estimate 40.00 %

Dividend Stability

0.80 Very Good

Dividend Score

5.17

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
1970	$0.00709	0.58%
1971	$0.00895	0.75%
1972	$0.00930	0.46%
1973	$0.0109	0.41%
1974	$0.0151	0.65%
1975	$0.0177	1.02%
1976	$0.0219	1.16%
1977	$0.0292	1.79%
1978	$0.0354	2.27%
1979	$0.0416	2.68%
1980	$0.0464	2.90%
1981	$0.0534	2.57%
1982	$0.0606	2.65%
1983	$0.0672	2.17%
1984	$0.0736	2.89%
1985	$0.0797	3.57%
1986	$0.0860	2.65%
1987	$0.101	2.39%
1988	$0.120	2.46%
1989	$0.140	2.68%
1990	$0.164	2.19%
1991	$0.193	2.20%
1992	$0.223	1.59%
1993	$0.253	2.04%
1994	$0.283	2.50%
1995	$0.320	2.35%
1996	$0.368	1.75%
1997	$0.425	1.71%
1998	$0.485	1.49%
1999	$0.545	1.32%
2000	$0.620	1.35%
2001	$0.700	1.37%
2002	$0.795	1.35%
2003	$0.925	1.67%
2004	$1.095	2.12%
2005	$1.275	2.03%
2006	$1.455	2.36%
2007	$1.620	2.44%
2008	$1.795	2.72%
2009	$1.930	3.18%
2010	$2.11	3.26%
2011	$2.25	3.58%
2012	$2.40	3.64%
2013	$2.59	3.66%
2014	$2.76	3.03%
2015	$2.95	2.82%
2016	$3.15	3.13%
2017	$3.32	2.87%
2018	$3.54	2.54%
2019	$3.75	2.94%
2020	$3.98	2.73%
2021	$4.19	2.68%
2022	$4.45	2.59%
2023	$4.70	2.64%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
JQC	Dividend Royal	2023-11-14	Monthly	22	6.56%	8.50
PHK	Dividend Royal	2023-11-10	Monthly	22	6.88%	8.50
PCF	Dividend King	2023-12-18	Monthly	38	7.05%	8.50
ZTR	Dividend Royal	2024-02-09	Monthly	37	8.35%	8.50
PVL	Dividend King	2023-11-15	Monthly	14	9.37%	8.50
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
SBR	Dividend Royal	2023-11-14	Monthly	38	7.74%	8.50
SCM	Dividend King	2023-12-15	Monthly	13	7.08%	8.50
MTR	Dividend Diamond	2023-10-30	Monthly	39	10.10%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.453	1.500	0.950	1.424	[0 - 0.5]
returnOnAssetsTTM	0.236	1.200	2.14	2.56	[0 - 0.3]
returnOnEquityTTM	0.572	1.500	4.76	7.14	[0.1 - 1]
payoutRatioTTM	0.218	-1.000	7.82	-7.82	[0 - 1]
currentRatioTTM	0.471	0.800	-2.65	-2.12	[1 - 3]
quickRatioTTM	0.777	0.800	-0.134	-0.107	[0.8 - 2.5]
cashRatioTTM	-0.471	1.500	-3.73	-5.59	[0.2 - 2]
debtRatioTTM	0.196	-1.500	6.74	-10.00	[0 - 0.6]
interestCoverageTTM	20.86	1.000	3.39	3.39	[3 - 30]
operatingCashFlowPerShareTTM	9.54	2.00	6.82	10.00	[0 - 30]
freeCashFlowPerShareTTM	7.70	2.00	6.15	10.00	[0 - 20]
debtEquityRatioTTM	0.489	-1.500	8.04	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.698	1.000	1.702	1.702	[0.2 - 0.8]
operatingProfitMarginTTM	0.258	1.000	6.85	6.85	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.690	1.000	7.28	7.28	[0.2 - 2]
assetTurnoverTTM	0.521	0.800	9.86	7.89	[0.5 - 2]
Total Score				7.59

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	9.05	1.000	9.19	0	[1 - 100]
returnOnEquityTTM	0.572	2.50	6.63	7.14	[0.1 - 1.5]
freeCashFlowPerShareTTM	7.70	2.00	7.43	10.00	[0 - 30]
dividendYielPercentageTTM	3.15	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	9.54	2.00	6.82	10.00	[0 - 30]
payoutRatioTTM	0.218	1.500	7.82	-7.82	[0 - 1]
pegRatioTTM	-3.98	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.259	1.000	6.03	0	[0.1 - 0.5]
Total Score				5.52

Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.